Active ingredientNitroxolineCat. No. P-N083-001CAS 4008-48-4Family · Pharmaceutical analytical standards
Nitroxoline
An antibacterial derived from 8-hydroxyquinoline, first marketed in Europe in 1962 to treat and prevent uncomplicated urinary tract infections; it works by sequestering metal ions that microbes need. This family brings together the active ingredient and labelled standards.
Did you know?In 2018 it was identified as a possible drug against the amoeba Balamuthia mandrillaris, and in 2021 it was successfully added to the treatment of a patient with a brain infection caused by this organism.
Go to the active ingredient →Active ingredientNitroxolineCat. No. P-N083-001CAS 4008-48-4
Isotopically labelledNitroxoline-d5Cat. No. P-N083-002No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.